Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.02B |
| 2 |
Apple
AAPL
|
+$837M |
| 3 |
Amazon
AMZN
|
+$811M |
| 4 |
Kenvue
KVUE
|
+$761M |
| 5 |
Blackstone
BX
|
+$581M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$438M |
| 2 |
Texas Instruments
TXN
|
+$235M |
| 3 |
Pfizer
PFE
|
+$205M |
| 4 |
LSI
Life Storage, Inc.
LSI
|
+$202M |
| 5 |
BKI
Black Knight, Inc. Common Stock
BKI
|
+$145M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.7% |
| 2 | Healthcare | 13.07% |
| 3 | Financials | 12.46% |
| 4 | Consumer Discretionary | 10.84% |
| 5 | Industrials | 8.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VAPO
4251
DELISTED
Vapotherm, Inc. Common Stock
VAPO
| $100K | ﹤0.01% |
39,705
+25
| +0.1% | +$78 |
|
|
HARP
4252
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $100K | ﹤0.01% |
24,913
+3,270
| +15% | +$24.2K |
|
4253
CareCloud
CCLD
$104M
| $99.9K | ﹤0.01% |
86,860
+10,637
| +14% | +$22.4K |
|
|
MLGO
4254
MicroAlgo
MLGO
$44.5M
| $99.7K | ﹤0.01% |
6
-1
| -14% | -$15.6K |
|
4255
Elutia
ELUT
$37.9M
| $99.6K | ﹤0.01% |
69,637
+68
| +0.1% | +$119 |
|
4256
LGL Group
LGL
$45.2M
| $99.5K | ﹤0.01% |
23,184
+7,177
| +45% | +$34.2K |
|
|
BZUN
4257
Baozun
BZUN
$167M
| $99.4K | ﹤0.01% |
32,067
| – | – |
|
4258
ASP Isotopes
ASPI
$504M
| $99.2K | ﹤0.01% |
+104,314
| New | +$108K |
|
4259
TOMI Environmental Solutions
TOMZ
$12.3M
| $98.4K | ﹤0.01% |
37,683
-3,843
| -9% | -$10.6K |
|
4260
MAIA Biotechnology
MAIA
$76M
| $98.1K | ﹤0.01% |
44,557
+10,570
| +31% | +$20.9K |
|
4261
WidePoint Corp
WYY
$101M
| $98K | ﹤0.01% |
56,983
-5,393
| -9% | -$9.98K |
|
4262
Real Brokerage
REAX
$349M
| $97.8K | ﹤0.01% |
67,441
+15,323
| +29% | +$26.7K |
|
4263
Cineverse
CNVS
$56.2M
| $97.7K | ﹤0.01% |
84,906
+16,909
| +25% | +$22.9K |
|
4264
SIFCO Industries
SIF
$161M
| $97K | ﹤0.01% |
26,411
+808
| +3% | +$2.2K |
|
|
EMPD
4265
Empery Digital
EMPD
$79.8M
| – | – |
0
| – | – |
|
4266
Serina Therapeutics
SER
$30M
| $95.9K | ﹤0.01% |
4,009
+1,229
| +44% | +$32.5K |
|
|
DOYU
4267
DouYu International Holdings
DOYU
$139M
| $95.8K | ﹤0.01% |
9,837
| – | – |
|
4268
Dominari Holdings
DOMH
$57.4M
| $94.6K | ﹤0.01% |
39,229
-4,082
| -9% | -$11.6K |
|
4269
Intensity Therapeutics
INTS
$11.2M
| $94.2K | ﹤0.01% |
+923
| New | +$128K |
|
|
JOAN
4270
DELISTED
JOANN, Inc. Common Stock
JOAN
| $93.7K | ﹤0.01% |
130,083
+6,179
| +5% | +$6.55K |
|
|
ELOX
4271
DELISTED
Eloxx Pharmaceuticals, Inc. Common Stock
ELOX
| $93.3K | ﹤0.01% |
19,588
-671
| -3% | -$3.76K |
|
|
TAIT
4272
DELISTED
Taitron Components
TAIT
| $93.2K | ﹤0.01% |
26,232
+13,101
| +100% | +$49.7K |
|
|
VBIV
4273
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $92.4K | ﹤0.01% |
138,729
+71,540
| +106% | +$87.7K |
|
|
ADAP
4274
DELISTED
Adaptimmune Therapeutics
ADAP
| $92K | ﹤0.01% |
117,909
| – | – |
|
4275
Martin Midstream Partners
MMLP
$95.5M
| $91.9K | ﹤0.01% |
33,068
| – | – |
|
Similar funds
Geode Capital Management's Q3 2023 Portfolio in Review
As of Q3 2023, Geode Capital Management held 4,905 positions worth $840B, down 1.3% from $851B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Geode Capital Management's Q3 2023 filing shows 147 new, 3,717 increased, 626 reduced and 142 closed positions. Its largest new stake was Kenvue: 32,873,626 shares worth $659M. The largest sale was Johnson & Johnson, an estimated $438M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 28% a quarter earlier, followed by Healthcare and Financials.
- Geode Capital Management's largest Q3 2023 buy was Kenvue: 32,873,626 shares worth $659M.
- Geode Capital Management added most to Microsoft in Q3 2023, an estimated $1.02B increase.
- Geode Capital Management's biggest Q3 2023 reduction was Johnson & Johnson, cutting an estimated $438M.
- Geode Capital Management fully exited Life Storage, Inc. in Q3 2023, selling an estimated $202M.
- Geode Capital Management's ten largest holdings make up 26% of its $840B portfolio in Q3 2023.
- Geode Capital Management opened 147 new positions and closed 142 in Q3 2023.
- Geode Capital Management's portfolio value fell 1.3% quarter-over-quarter to $840B.
Based on Geode Capital Management's 13F filing for Q3 2023, filed 13 Nov 2023.